News & Events about Bristol Myers Squibb Co.
Global Breast Cancer Market Size Projected To Hit $70 Billion in Revenues By 2030 Global Breast Cancer Market Size Projected To Hit $70 Billion in Revenues By 2030 PR Newswire PALM BEACH, Fla., May 5, 2023 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 5, 2023 /PRNewswire/ -- Breast...
Northeast Investment Management lowered its position in Bristol-Myers Squibb (NYSE:BMY Get Rating) by 14.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The firm owned 10,531 shares of the biopharmaceutical ...
Eudaimonia Partners LLC reduced its position in Bristol-Myers Squibb (NYSE:BMY Get Rating) by 3.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,490 shares of the biopharmaceutical companys stock after selling 323 ...
Business Wire
2 months ago
Bristol Myers Squibb (NYSE: BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi (lisocabtagene maraleucel) for the treatment of adult patients with diffuse large B-cell lymphoma (DLBCL), high...
Business Wire
2 months ago
Bristol Myers Squibb (NYSE: BMY) today announced three-year follow-up results from the Phase 3 CheckMate -816 trial, demonstrating sustained clinical benefits with three cycles of Opdivo (nivolumab) in combination with platinum-based chemotherapy for the neoadjuvant treatment of patients with...